COVID–19 Emergency Manufacturing Act of 2020
Latest action · Jun 1, 2020 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJun 1, 2020
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
COVID-19 Emergency Manufacturing Act of 2020
This bill establishes within the Department of Health and Human Services (HHS) an Emergency Office of Manufacturing for Public Health to manufacture and distribute medical products to address COVID-19 (i.e., coronavirus disease 2019) or medical products that are on shortage or vulnerable to shortage.The office must (1) obtain the rights to manufacture the applicable medicines, ingredients, diagnostic tests, medical devices, personal protective equipment, and supplies; (2) manufacture or contract to manufacture such items; and (3) construct, or enter into construction contracts for, facilities to manufacture certain medicines, such as vaccines.
HHS may issue involuntary licenses allowing the office to make, use, sell, import, or export an invention related to an applicable drug, biological product, or device and to use clinical trial data and confidential information. Such a license must provide the rights holder with reasonable compensation.
The office must (1) provide such COVID-19 products at no cost to federal, state, local, and other health programs and certain domestic health care providers and suppliers; (2) offer COVID-19 products at cost to other commercial and international entities; and (3) offer other medical products to entities at a fair price, based on cost and other considerations.
The office shall prioritize the manufacture of certain COVID-19 products and meet manufacturing timelines specified in the bill.
Cosponsors
Members who signed on, in the order they did.
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Jun 1, 2020 |
Actions 2
Everything that happened, newest first.
- Jun 1, 2020Introduced in Senate
- Jun 1, 2020Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46741 | Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress | Report | Mar 31, 2021 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 187 | Pandemic Emergency Manufacturing Act of 2021 | Reintroduced Bill | Feb 3, 2021 |
| HR 7113 | COVID–19 Emergency Manufacturing Act of 2020 | Related bill | Jun 4, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.
- Short Title(s) as Introduced
- COVID–19 Emergency Manufacturing Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Blood and blood diseases
- Cardiovascular and respiratory health
- Congressional oversight
- Corporate finance and management
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Emergency medical services and trauma care
- Executive agency funding and structure
- Federal officials
- Genetics
- Government ethics and transparency, public corruption
- Government information and archives
- Government studies and investigations
- Health
- Health personnel
- Health technology, devices, supplies
- Immunology and vaccination
- Indian social and development programs
- Infectious and parasitic diseases
- Inflation and prices
- Licensing and registrations
- Manufacturing
- Marketing and advertising
- Medical tests and diagnostic methods
- Minority health
- Prescription drugs
- Public contracts and procurement
- Public participation and lobbying
- State and local government operations
- Strategic materials and reserves
- Worker safety and health
Text 1
Each version as it was printed, newest first.
- Jun 1, 2020Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.